These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3283290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R.
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [Abstract] [Full Text] [Related]

  • 3. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
    Korn A, Da Prada M, Raffesberg W, Allen S, Gasic S.
    J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: influence of dosage regimen.
    Müller T, Gieschke R, Ziegler WH.
    J Neural Transm Suppl; 1988; 26():105-14. PubMed ID: 3162949
    [Abstract] [Full Text] [Related]

  • 5. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
    Bieck PR.
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between orally administered tyramine and moclobemide.
    Zimmer R, Puech AJ, Philipp F, Korn A.
    Acta Psychiatr Scand Suppl; 1990 Aug; 360():78-80. PubMed ID: 2248083
    [Abstract] [Full Text] [Related]

  • 8. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
    Berlin I, Zimmer R, Cournot A, Payan C, Pedarriosse AM, Puech AJ.
    Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
    [Abstract] [Full Text] [Related]

  • 9. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 Sep; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 10. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW, Maguire KP, Davies BM.
    Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
    [Abstract] [Full Text] [Related]

  • 11. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD, Mellsop GW.
    Fundam Clin Pharmacol; 1989 Nov; 3(1):47-52. PubMed ID: 2714732
    [Abstract] [Full Text] [Related]

  • 12. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE.
    J Neural Transm Suppl; 1989 Nov; 28():5-20. PubMed ID: 2677242
    [Abstract] [Full Text] [Related]

  • 13. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
    Korn A, Da Prada M, Raffesberg W, Gasic S, Eichler HG.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
    [Abstract] [Full Text] [Related]

  • 14. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M, Kettler R, Burkard WP, Lorez HP, Haefely W.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():7-12. PubMed ID: 2248079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potentiation of the pressor effect of intravenously administered tyramine during moclobemide treatment.
    Zimmer R, Fischbach R, Breuel HP.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():76-7. PubMed ID: 2248082
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P, Langley RW, Tavernor S, Pyykkö K, Scheinin M, Szabadi E, Bradshaw CM.
    Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.